Sale!

Cagrilintide

Price range: $116.00 through $195.00

Cagrilintide is a novel, investigational, long-acting synthetic analog of the natural hormone Amylin. It is an amylin receptor agonist (and calcitonin receptor agonist) developed by Novo Nordisk for once-weekly subcutaneous administration. Its primary action is to suppress appetite, promote satiety, and delay gastric emptying. While effective as a monotherapy for weight loss, it is most promising in combination with the $text{GLP}-1$ agonist semaglutide (CagriSema), where it targets a complementary pathway to achieve significantly greater reductions in body weight and better metabolic control.

Description

Cagrilintide is a long-acting amylin receptor agonist — a different hormonal target entirely from GLP-1, since amylin is co-secreted with insulin by pancreatic beta cells and acts on satiety and gastric emptying through its own receptor family. Researchers use it to study appetite regulation via a pathway independent of incretin signalling.

Its main research relevance right now is as the amylin component of CagriSema (cagrilintide + semaglutide) combination studies, where dual-hormone activation has shown additive effects on weight-related endpoints compared with either hormone class alone in trial data.

After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water immediately before use; store lyophilised vials refrigerated and protected from light.

Additional information

Optional Specification

5mg*10vials/10mg*10vials, 10mg*10vials/10mg*10vials